Literature DB >> 4562823

A randomized clinical trial of daunorubicin and a combination of prednisone, vincristine, 6-mercaptopurine, and methotrexate in adult acute nonlymphocytic leukemia.

P H Wiernik, A A Serpick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4562823

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  8 in total

Review 1.  Inching toward cure of acute myeloid leukemia: a summary of the progress made in the last 50 years.

Authors:  Peter H Wiernik
Journal:  Med Oncol       Date:  2014-07-22       Impact factor: 3.064

Review 2.  Advances in the management of adult acute myelogenous leukaemia.

Authors:  J A Whittaker
Journal:  Br Med J       Date:  1980-10-11

Review 3.  Hair disorders in patients with cancer.

Authors:  Azael Freites-Martinez; Jerry Shapiro; Shari Goldfarb; Julie Nangia; Joaquin J Jimenez; Ralf Paus; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2018-04-14       Impact factor: 11.527

Review 4.  Curative chemotherapy for acute myeloid leukemia: the development of high-dose ara-C from the laboratory to bedside.

Authors:  R L Capizzi
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

5.  Optimum Induction Chemotherapy for Pediatric Acute Myeloid Leukemia: Experience From A Developing Country.

Authors:  Tariq Ghafoor; Shakeel Ahmed; Sumaira Khalil; Tanzeela Farah
Journal:  J Pediatr Pharmacol Ther       Date:  2020

6.  Adriamycin and daunorubicin inhibition of mutant T4 DNA polymerases.

Authors:  M F Goodman; M J Bessman; N R Bachur
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

7.  Anthracycline dose intensification in young adults with acute myeloid leukemia.

Authors:  Eric Padron; Hugo Fernandez
Journal:  Ther Adv Hematol       Date:  2012-02

8.  Remission-induction regimens in acute nonlymphocytic leukemia.

Authors:  D C Brennan; J P Lewis
Journal:  West J Med       Date:  1980-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.